- Home
- OPT vs HFWA Comparison
OPT vs HFWA Comparison
Compare OPT & HFWA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPT
- HFWA
- Stock Information
- Founded
- OPT 1984
- HFWA 1927
- Country
- OPT Australia
- HFWA United States
- Employees
- OPT N/A
- HFWA N/A
- Industry
- OPT Biotechnology: Biological Products (No Diagnostic Substances)
- HFWA Banks
- Sector
- OPT Health Care
- HFWA Finance
- Exchange
- OPT Nasdaq
- HFWA Nasdaq
- Market Cap
- OPT 767.9M
- HFWA 912.4M
- IPO Year
- OPT 2020
- HFWA N/A
- Fundamental
- Price
- OPT $3.22
- HFWA $24.02
- Analyst Decision
- OPT Strong Buy
- HFWA Buy
- Analyst Count
- OPT 1
- HFWA 5
- Target Price
- OPT $12.00
- HFWA $24.40
- AVG Volume (30 Days)
- OPT 13.0K
- HFWA 152.4K
- Earning Date
- OPT 08-30-2024
- HFWA 01-23-2025
- Dividend Yield
- OPT N/A
- HFWA 3.58%
- EPS Growth
- OPT N/A
- HFWA N/A
- EPS
- OPT N/A
- HFWA 1.08
- Revenue
- OPT $261,859.00
- HFWA $203,985,000.00
- Revenue This Year
- OPT N/A
- HFWA N/A
- Revenue Next Year
- OPT $46,864.64
- HFWA $9.41
- P/E Ratio
- OPT N/A
- HFWA $23.81
- Revenue Growth
- OPT N/A
- HFWA N/A
- 52 Week Low
- OPT $1.79
- HFWA $16.55
- 52 Week High
- OPT $5.45
- HFWA $27.58
- Technical
- Relative Strength Index (RSI)
- OPT 40.67
- HFWA 34.05
- Support Level
- OPT $3.15
- HFWA $25.78
- Resistance Level
- OPT $3.78
- HFWA $26.54
- Average True Range (ATR)
- OPT 0.18
- HFWA 0.71
- MACD
- OPT -0.00
- HFWA -0.28
- Stochastic Oscillator
- OPT 25.91
- HFWA 4.01
About OPT Opthea Limited
Opthea Ltd operates in one industry being the medical technology and healthcare. It is focused on developing biological therapeutics for eye diseases. The company is developing a novel biologic therapy, OPT-302, for the treatment of eye diseases. Its products are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors C and D and R3 targets. Opthea's development activities are based on an intellectual property portfolio covering key targets Vascular Endothelial Growth Factors VEGF-C, VEGF-D and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. The company geographically operates Australia and United States.
About HFWA Heritage Financial Corporation
Heritage Financial Corp is a bank holding company. The company through its subsidiary provides commercial lending and deposit relationships with small businesses and their owners in its market areas and attracts deposits from the general public. It accepts various deposit products, such as noninterest demand accounts, money market accounts, savings accounts, and certificates of deposit. Besides, the Bank also makes real estate construction loans, land development loans, and consumer loans, and originates first mortgage loans on residential properties mainly located in its market area. Geographically, all the business activity functions through the region of the United States.